As of 2026-09-12, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (80.00) USD. This relative valuation is based on P/E multiples. With the latest stock price at 104.71 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -176.4%.
The range of the Relative Valuation is (70.12) - (88.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 29.7x | 26.5x |
| Forward P/E multiples | 23.4x - 30.4x | 26.9x |
| Fair Price | (70.12) - (88.99) | (80.00) |
| Upside | -167.0% - -185.0% | -176.4% |
| Date | P/E |
| 2026-09-10 | -34.11 |
| 2026-09-09 | -33.73 |
| 2026-09-08 | -33.97 |
| 2026-09-04 | -34.29 |
| 2026-09-03 | -35.00 |
| 2026-09-02 | -35.18 |
| 2026-09-01 | -34.95 |
| 2026-08-31 | -35.42 |
| 2026-08-28 | -35.77 |
| 2026-08-27 | -37.55 |
| 2026-08-26 | -37.33 |
| 2026-08-25 | -37.83 |
| 2026-08-24 | -37.19 |
| 2026-08-21 | -36.71 |
| 2026-08-20 | -36.35 |
| 2026-08-19 | -38.62 |
| 2026-08-18 | -38.46 |
| 2026-08-17 | -38.53 |
| 2026-08-14 | -38.54 |
| 2026-08-13 | -38.72 |
| 2026-08-12 | -39.25 |
| 2026-08-11 | -37.66 |
| 2026-08-10 | -38.54 |
| 2026-08-07 | -38.59 |
| 2026-08-06 | -37.41 |
| 2026-08-05 | -36.95 |
| 2026-08-04 | -35.30 |
| 2026-08-03 | -34.30 |
| 2026-07-31 | -33.12 |
| 2026-07-30 | -35.29 |
| 2026-07-29 | -35.55 |
| 2026-07-28 | -36.06 |
| 2026-07-27 | -35.42 |
| 2026-07-24 | -34.07 |
| 2026-07-23 | -34.26 |
| 2026-07-22 | -34.70 |
| 2026-07-21 | -35.58 |
| 2026-07-20 | -34.91 |
| 2026-07-17 | -35.58 |
| 2026-07-16 | -35.41 |
| 2026-07-15 | -36.61 |
| 2026-07-14 | -36.70 |
| 2026-07-13 | -35.87 |
| 2026-07-10 | -36.18 |
| 2026-07-09 | -38.54 |
| 2026-07-08 | -38.19 |
| 2026-07-07 | -38.20 |
| 2026-07-06 | -37.27 |
| 2026-07-02 | -38.10 |
| 2026-07-01 | -36.85 |